CHS Pharma Inc.

Dedicated to the commercialization of an innovative treatment for a precancerous skin condition commonly known as Actinic Keratosis.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Jupiter, FL, USA
  • Currency USD
  • Founded October 2005
  • Employees 2
  • Website chspharma.com

Company Summary

Rapidly emerging Pre-Clinical stage biotech company. The company has acquired its IP portfolio that was previously licensed from Florida Atlantic University (FAU) and Hospital for Special Surgery (HSS). We currently have 4 US patents issued, 1 EU and 1 US patent allowed, and 8 other applications are pending. Our first drug, CHS-101, selectively destroys cancer cells while protecting healthy cells.

Team

  • Stephen Chakoff
    President and CEO

  • Saeid Rezvankhah
    COO and EVP

  • Saeid Rezvankhah

Advisors

  • Dale Bergman
    Lawyer
    Unconfirmed
    Michael Singer, CPA
    Accountant
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free